Abstract Background The proliferation of Novel Psychoactive Substances (NPS) presents a
challenge for global drug policy. The ease of online drug purchase and the emergence of …

Background: Generic drug legislation, ie, simultaneously banning groups of drugs, has been
introduced worldwide to counteract the trade and use of emerging “new psychoactive …

Currently, novel psychoactive substance (NPS) use presents a challenging issue for
authorities. To effectively tackle the use of NPS, a deeper understanding of the motivations …

Abstract Introduction Synthetic cannabinoids (ie Spice) are a major public health problem in
UK prisons, however, research in this area is limited. Here we aimed to draw comparisons …

Aim This research aimed to describe how the characteristics of deaths following drug use
changed during the COVID-19 pandemic in England, and how this can inform future strategy …

Abstract Background and aims The United Kingdom (UK) Psychoactive Substances Act
(PSA), implemented on the 26th May 2016, made the production, supply and sale of all non …

Problematic substance use among women is increasing, with global prevalence data
indicating that 46 million women have an alcohol use disorder (1), the highest prevalence of …

Increasing popularity and known shortfalls in the regulation of electronic cigarettes (ECs)
emphasises the urgent need for closer content monitoring and for comprehensible …

Background Psychedelic drugs are increasingly visible in society once more, but their risks
and adverse effects have received less attention than perhaps they should. While fatalities …

Introduction 25B-NBOH is a synthetic hallucinogen closely related to the “NBOMe” family of
N-substituted 2C phenethylamine derivatives. There have been no published reports …